private label skincare manufacturer

1. Why ‘exosome skincare’ presents such a challenge Exosome products have become all the rage in the industry in recent years; not only have before-and-after comparison videos quickly flooded TikTok—search volumes have surged by over 1,500% in just two years—but the market is projected to reach nearly US$2 billion by 2032. “Salmon” and “exosome” serums have long been established as bestsellers by Korean beauty giants such as Medicube and VT Cosmetics. Consequently, many B2B buyers naturally wish to get a slice of the pie. The problem, however, is that exosomes derived from humans or animals are not advisable and remain in a legal grey area. EU cosmetics regulations explicitly prohibit the use of human-derived exosomes. The US Food and Drug Administration (FDA) has not yet approved any exosome-based cosmetics. In contrast, plant-derived “exosome-like” nanovesicles—also known as plant-derived liposomes (ELNs)—represent a cleaner, safer alternative. They deliver similar benefits whilst posing minimal compliance risks.     2. Three Technical Pathways, One Clear Winner Currently, three options are available to brands and retailers. First, human or animal exosomes, which possess extremely high biological activity but also pose significant ethical and regulatory risks. Second, DNA-derived active ingredients extracted from the well-known salmon PDRN, often marketed under the umbrella of ‘exosomes’. Whilst generally accepted, their INCI name must be listed as ‘Sodium DNA’. Third, plant-derived active vesicles that are not included on any banned lists and are free from ethical or moral controversy. They can exert cell signalling effects without attracting the attention of regulatory authorities. Major raw material suppliers have increasingly shifted towards this direction, as it is safer and offers a clear and well-defined compliance pathway.     3. Trends among major raw material suppliers At In-cosmetics Global 2026, DSM-Firmenich launched Exovive Lift, a plant-derived active vesicle made from Alpine apples, Mediterranean citrus and Sicilian papaya. A two-month clinical trial demonstrated that this ingredient significantly reduces wrinkles, with effects akin to making the skin appear eight years younger, whilst boosting skin elasticity by 30%. This points to the direction in which the industry is heading. Although the EU restricts the use of human exosomes, it recognises plant-derived exosomes (ELNs) as a compliant alternative. In the US, the threshold for declaring plant-derived exosome ingredients under their INCI names is significantly lower. For brands targeting the European or US markets, plant-derived vesicles are not only a current trend but also a sound long-term choice.     4. Real production data from our factory At our GMPC-certified factory in Guangzhou, we have produced a plant-peptide repair serum utilising plant-derived active vesicles. An independent laboratory conducted a four-week trial involving 30 participants. The results showed a reduction in the appearance of fine lines of 18% to 22%, an improvement in skin elasticity of 15% to 18%, and an increase in hydration of 28% to 32%. All our production takes place in a Class 100,000 cleanroom; we track every batch and subject each formulation to 720 hours of stability testing. This is by no means an ‘exosome’ marketing gimmick – it is a genuine skincare product that meets export standards and ensures your compliance with regulations. We offer custom concentrations, synergistic active ingredient formulations and complete compliance documentation (INCI: Sodium DNA, CPNP, Halal certification, FDA). You can receive samples within 15 days, and our minimum order quantities are low. We have already shipped to brands in the US, Germany and the Middle East.     5. Why this matters for your private label brand Compared to popular Korean ‘salmon’ or ‘exosome’ serums, our plant-based version offers equivalent efficacy whilst keeping you entirely free from legal disputes. This high-tech repair serum, utilising plant-derived vesicles, provides you with a ‘clean’ product narrative. Positioned as a gentle post-procedure serum, it soothes redness, strengthens the skin barrier and promotes natural repair, making it particularly suitable for clean beauty, vegan or sensitive skin ranges.     6. Summary The exosome craze is very real, but replicating ingredients that carry legal risks is by no means a wise move. Please opt for plant-based alternatives—they deliver comparable results whilst completely avoiding compliance risks. Are you looking for a post-procedure serum, daily barrier care products, or a complete sensitive skin skincare range? Please feel free to contact us to request samples or arrange a technical consultation.